Stu Mackey joined Daiichi Sankyo in April 2013.  He chairs the Senior Licensing Committee and works directly with senior management in Tokyo, the U.S. and Europe on key licensing and business development projects. 

He began his career as an associate at the law firm of Folger Levin and Kahn in San Francisco before joining the Law Department at Amgen in 1999.  He served in various capacities in the Law Department before moving to the Licensing group in 2003.  After leading the negotiations team within Amgen Licensing, he moved into Corporate Development and Strategy, where among other responsibilities, he served as Managing Director of Amgen Ventures, the company’s venture capital arm.  In 2009, he left Amgen to become the Chief Business Officer of Santaris Pharma, before later returning to Amgen as Deputy General Manager of Amgen’s global biosimilars unit. 

Mr. Mackey graduated from Harvard University where he studied economics and received his J.D. from Boalt Hall School of Law, University of California at Berkeley.